Pharmicell (005690) — Strategic Asset Allocation Index
Pharmicell (005690) has a Strategic Asset Allocation Index of 5.4% as of June 2014. Strategic assets (PP&E of ₩4.57 Billion plus long-term investments of ₩2.50 Million) total ₩4.57 Billion, measured against net assets of ₩84.27 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Pharmicell Strategic Asset Allocation Index (2010–2013)
This chart shows how Pharmicell's Strategic Asset Allocation Index has evolved across 4 annual periods from 2010 to 2013. As of June 2014, the index stands at 5.4%, representing strategic assets of ₩4.57 Billion against net assets of ₩84.27 Billion KRW. Explore 005690 cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Pharmicell (2010–2013)
The table below presents the year-by-year Strategic Asset Allocation Index for Pharmicell from 2010 to 2013, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Pharmicell market capitalisation.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2013 | 7.0% | ₩5.73 Billion | ₩5.73 Billion | ₩2.50 Million | ₩82.42 Billion | ▼ -0.3 pp |
| 2012 | 7.3% | ₩7.41 Billion | ₩6.03 Billion | ₩1.38 Billion | ₩101.58 Billion | ▲ +1.7 pp |
| 2011 | 5.5% | ₩4.60 Billion | ₩3.67 Billion | ₩930.00 Million | ₩82.82 Billion | ▼ -10.8 pp |
| 2010 | 16.3% | ₩1.61 Billion | ₩1.23 Billion | ₩380.00 Million | ₩9.90 Billion | — |